David H Wang sold $8.8M of ACMR
See Remarks at ACM Research, Inc.. 100,002 shares at an average of $88.35, traded Jun 3, 2026, filed Jun 5, 2026.
Score components
- +15RoleOfficer
- +25Trade size$8.8M at market
- +5Share of holdings soldSold 12% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-26-024280, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | MOption exercise Class A Common Stock10b5-1 | +60,000 | $1.00 | $60k | 862,708 | Jun 5, 2026 |
| Jun 3, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -4,300 | $87.57 | $377k | 858,408 | Jun 5, 2026 |
| Jun 3, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -6,295 | $88.98 | $560k | 852,113 | Jun 5, 2026 |
| Jun 3, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -32,450 | $89.84 | $2.9M | 819,663 | Jun 5, 2026 |
| Jun 3, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -9,925 | $90.78 | $901k | 809,738 | Jun 5, 2026 |
| Jun 3, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -5,843 | $92.38 | $540k | 803,895 | Jun 5, 2026 |
| Jun 3, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -1,187 | $93.04 | $110k | 802,708 | Jun 5, 2026 |
| Jun 4, 2026 | MOption exercise Class A Common Stock10b5-1 | +40,002 | $1.00 | $40k | 842,710 | Jun 5, 2026 |
| Jun 4, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -2,060 | $83.86 | $173k | 840,650 | Jun 5, 2026 |
| Jun 4, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -17,543 | $85.11 | $1.5M | 823,107 | Jun 5, 2026 |
| Jun 4, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -10,992 | $86.07 | $946k | 812,115 | Jun 5, 2026 |
| Jun 4, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -8,581 | $87.13 | $748k | 803,534 | Jun 5, 2026 |
| Jun 4, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -826 | $87.91 | $73k | 802,708 | Jun 5, 2026 |
| Jun 3, 2026 | MOption exercise Stock Optionderivative10b5-1 | -60,000 | $0.00 | $0 | 310,002 | Jun 5, 2026 |
| Jun 4, 2026 | MOption exercise Stock Optionderivative10b5-1 | -40,002 | $0.00 | $0 | 270,000 | Jun 5, 2026 |
Related signals
Other insiders at ACM Research, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | ACM Research, Inc. | David H Wang See Remarks | $11M 140,000 shares | -16% | |
| 33Weak | ACM Research, Inc. | Mark McKechnie See Remarks | $4.3M 55,199 shares | -98% | |
| 24Weak | ACM Research, Inc. | Haiping Dun director | $406k 5,000 shares | -100% | |
| 18Weak | ACM Research, Inc. | Sotheara Cheav See remarks | $1.6M 18,750 shares | -17% | |
| 15Weak | ACM Research, Inc. | Haiping Dun director | $331k 5,000 shares | -100% | |
| 13Weak | ACM Research, Inc. | Charles C Pappis director | $260k 5,000 shares | -100% | |
| 25Weak | ACM Research, Inc. | David H Wang See Remarks | $5.2M 110,000 shares | -13% | |
| 40Moderate | ACM Research, Inc. | Mark McKechnie See Remarks | $4.5M 98,551 shares | -162% | |
| 30Weak | ACM Research, Inc. | Tracy Liu director | $2.9M 60,000 shares | -39% | |
| 27Weak | ACM Research, Inc. | Haiping Dun director | $217k 5,000 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.